Akebia Therapeutics | AKBA - Dividendenrendite

Aktienkurs
1.36
Täglich Wechseln
0.04 3.03%
Monatlich
7.94%
Jährlich
-29.17%
Q1 Prognose
1.30




Dy Veränderung Datum
Akebia Therapeutics 0 0 2025-03
Amgen 2.95 0.38 2025-12
Astellas Pharma 3.63 1.59 2025-12
AstraZeneca USD 1.74 0.4 2025-12
Bayer 0.3 0.09 2025-12
Celltrion 0.42 0.04 2025-03
Cspc Pharmaceutical CNY 2.6 0.83 2025-09
Deva Holding AS 0.18 0.07 2023-09
Fresenius Medical Care 3.53 0.31 2025-12
GlaxoSmithKline 4.57 1.52 2025-12
J&J 2.5 0.32 2025-12
Karyopharm Therapeutics 0 0 2025-03
Laboratorios Farma 2.15 0.91 2023-12
Lexicon Pharmaceuticals 0 0 2025-03
Medical Developments International 1.42 0.59 2021-06
Nektar Therapeutics 0 0 2025-03
Ovoca Bio EUR 0 0 2024-12
Pharma Mar 0.88 0.12 2025-09
Qiagen NV USD 0.56 0 2025-12
Regeneron Pharmaceuticals 0.46 0.01 2025-12
Roche Holding 2.96 0.8 2025-12
Sanofi 4.74 0.25 2025-12
Sartorius 0.3 0.08 2025-12
Sino Biopharmaceutical CNY 1.35 0.49 2025-06
Vanda Pharmaceuticals 0 0 2025-03
Zhangzhou Pientzehuang Pharmaceutical 1.64 0.15 2025-09